NO986103L - Substituerte indazol-derivater og deres anvendelse som fosfodiesterase (PDE)type IV - og tumornekrose-faktor (TNF)inhibitorer - Google Patents

Substituerte indazol-derivater og deres anvendelse som fosfodiesterase (PDE)type IV - og tumornekrose-faktor (TNF)inhibitorer

Info

Publication number: NO986103L
Authority: NO; Norway
Prior art keywords: pde; phosphodiesterase; tnf; inhibitors; type
Prior art date: 1996-06-25

Application number

NO986103A

Other languages

English (en)

Other versions

NO986103D0 (no

Inventor

Anthony Marfat

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-25

Filing date

1998-12-23

Publication date

1998-12-23

1998-12-23 Application filed by Pfizer filed Critical Pfizer

1998-12-23 Publication of NO986103D0 publication Critical patent/NO986103D0/no

1998-12-23 Publication of NO986103L publication Critical patent/NO986103L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO986103A 1996-06-25 1998-12-23 Substituerte indazol-derivater og deres anvendelse som fosfodiesterase (PDE)type IV - og tumornekrose-faktor (TNF)inhibitorer NO986103L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2038596P	1996-06-25	1996-06-25
PCT/IB1997/000630 WO1997049702A1 (en)	1996-06-25	1997-06-02	Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors

Publications (2)

Publication Number	Publication Date
NO986103D0 NO986103D0 (no)	1998-12-23
NO986103L true NO986103L (no)	1998-12-23

Family

ID=21798354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO986103A NO986103L (no)	1996-06-25	1998-12-23	Substituerte indazol-derivater og deres anvendelse som fosfodiesterase (PDE)type IV - og tumornekrose-faktor (TNF)inhibitorer

Country Status (42)

Country	Link
US (1)	US6040329A (no)
EP (1)	EP0912558B1 (no)
JP (1)	JP3152940B2 (no)
KR (1)	KR20000022516A (no)
CN (1)	CN1080260C (no)
AP (1)	AP1025A (no)
AR (1)	AR007456A1 (no)
AT (1)	ATE244713T1 (no)
AU (1)	AU716376B2 (no)
BG (1)	BG64052B1 (no)
BR (1)	BR9712782A (no)
CA (1)	CA2258285C (no)
CO (1)	CO4900056A1 (no)
CZ (1)	CZ423398A3 (no)
DE (1)	DE69723447T2 (no)
DK (1)	DK0912558T3 (no)
DZ (1)	DZ2254A1 (no)
EA (1)	EA002274B1 (no)
ES (1)	ES2201299T3 (no)
GT (1)	GT199700075A (no)
HN (1)	HN1997000079A (no)
HR (1)	HRP970350B1 (no)
HU (1)	HUP9903009A3 (no)
ID (1)	ID18579A (no)
IL (1)	IL127036A (no)
IS (1)	IS4910A (no)
MA (1)	MA24225A1 (no)
MY (1)	MY116915A (no)
NO (1)	NO986103L (no)
NZ (1)	NZ332752A (no)
OA (1)	OA10934A (no)
PA (1)	PA8432301A1 (no)
PL (1)	PL330974A1 (no)
PT (1)	PT912558E (no)
SI (1)	SI0912558T1 (no)
SK (1)	SK176598A3 (no)
TN (1)	TNSN97108A1 (no)
TR (1)	TR199802685T2 (no)
TW (1)	TW434237B (no)
WO (1)	WO1997049702A1 (no)
YU (1)	YU60198A (no)
ZA (1)	ZA975581B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2258728C (en)	1996-06-19	2011-09-27	Rhone Poulenc Rorer Limited	Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
BR9712005A (pt) *	1996-09-04	1999-08-24	Pfizer	Derivados de indazol e seus usos como inibidores de fosfodiesterase (pde) tipo IV e produ-Æo do fator de necrose de tumor (tnf)
US6248746B1 (en)	1998-01-07	2001-06-19	Euro-Celtique S.A.	3-(arylalkyl) xanthines
EA200000385A1 (ru) *	1997-11-04	2000-10-30	Пфайзер Продактс Инк.	Терапевтически активные соединения на основе индазольной биоизостерической замены катехина в ингибиторах фосфодиэстеразы типа vi (pde4)
EA200000488A1 (ru) *	1997-11-04	2000-10-30	Пфайзер Продактс Инк.	Замена катехина на биоизостеру индазола в терапевтически активных соединениях
PT1244649E (pt) *	1999-12-23	2005-06-30	Icos Corp	Inibidores de fosfodiesterase especificos de mfa ciclica
US6362213B1 (en)	1999-12-23	2002-03-26	Icos Corporation	Cyclic AMP-specific phosphodiesterase inhibitors
US6953774B2 (en)	2000-08-11	2005-10-11	Applied Research Systems Ars Holding N.V.	Methods of inducing ovulation
US7205320B2 (en)	2001-01-22	2007-04-17	Memory Pharmaceuticals Corp.	Phosphodiesterase 4 inhibitors
US7153871B2 (en)	2001-01-22	2006-12-26	Memory Pharmaceuticals Corporation	Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
CA2440842A1 (en) *	2001-04-16	2002-10-24	Eisai Co., Ltd.	Novel 1h-indazole compounds
WO2003051344A1 (en)	2001-12-14	2003-06-26	Applied Research Systems Ars Holding N.V.	Methods of inducing ovulation_using a non-polypeptide camp level modulator
MXPA05000827A (es)	2002-07-19	2005-08-29	Memory Pharm Corp	Inhibidores de fosfodiesterasa 4, incluyendo analogos de anilina y difenilamina n-sustituidos.
JP2006502995A (ja) *	2002-07-19	2006-01-26	メモリー・ファーマシューティカルズ・コーポレイション	ホスホジエステラーゼ４阻害剤としての６−アミノ−１ｈ−インダゾール及び４−アミノベンゾフラン化合物
EP1569908B1 (en) *	2002-11-19	2010-09-15	Memory Pharmaceuticals Corporation	Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
JP2006523719A (ja) *	2003-04-18	2006-10-19	メモリー・ファーマシューティカルズ・コーポレイション	ホスホジエステラーゼ４抑制剤としてのピラゾール誘導体
US20090048255A1 (en) *	2003-07-21	2009-02-19	Schumacher Richard A	Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
MY141255A (en) *	2003-12-11	2010-03-31	Memory Pharm Corp	Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
CA2584317A1 (en) *	2004-10-15	2006-04-27	Memory Pharmaceuticals Corporation	Pyrazole derivatives as phosphodiesterase 4 inhibitors
US7601847B2 (en)	2004-10-26	2009-10-13	Wyeth	Preparation and purification of 4-(indazol-3-yl)phenols
WO2006129158A2 (en) *	2005-05-30	2006-12-07	Ranbaxy Laboratories Limited	3 - indazolyl - isoxazoline derivatives as inhibitors of phosphodiesterase type - i
EP1928437A2 (en)	2005-08-26	2008-06-11	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation
EP2258359A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1928866A1 (en)	2005-09-05	2008-06-11	Ranbaxy Laboratories Limited	Substituted indazoles as inhibitors of phosphodiesterase type-iv
US7915286B2 (en)	2005-09-16	2011-03-29	Ranbaxy Laboratories Limited	Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
JP2009512711A (ja)	2005-10-21	2009-03-26	ブレインセルス，インコーポレイティド	Ｐｄｅ阻害による神経新生の調節
WO2007053596A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenesis by modulating angiotensin
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
DK2124944T3 (da)	2007-03-14	2012-04-23	Ranbaxy Lab Ltd	Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
WO2010003084A2 (en) *	2008-07-02	2010-01-07	Memory Pharmaceuticals Corporation	Phosphodiesterase 4 inhibitors
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
BR112012010041A2 (pt) *	2009-10-30	2016-05-24	Janssen Pharmaceutica Nv	derivados de imidazo [1,2-b] piridazina e seu uso como inibidores de pde10
EP2804603A1 (en)	2012-01-10	2014-11-26	President and Fellows of Harvard College	Beta-cell replication promoting compounds and methods of their use
US20150125438A1 (en) *	2012-07-20	2015-05-07	Sang Jae Kim	Anti-Inflammatory Peptides and Composition Comprising the Same
EP3137454A1 (en)	2014-04-28	2017-03-08	Pfizer Inc.	Heteroaromatic compounds and their use as dopamine d1 ligands
KR20220167441A (ko) *	2021-06-11	2022-12-21	주식회사 메타센테라퓨틱스	신규한 인돌 유도체 및 이의 최종당화산물 관련 질환의 치료 용도
KR20220167804A (ko) *	2021-06-11	2022-12-22	주식회사 메타센테라퓨틱스	인돌 유도체를 포함하는 최종당화산물 관련 질환의 치료용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB753573A (en) *	1953-06-17	1956-07-25	Ici Ltd	New dyestuffs intermediates
GB8707051D0 (en) *	1986-04-15	1987-04-29	Ici America Inc	Heterocyclic carboxamides
PT100441A (pt) *	1991-05-02	1993-09-30	Smithkline Beecham Corp	Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
TW223004B (no) *	1991-11-25	1994-05-01	Sumitomo Chemical Co
US5444038A (en) *	1992-03-09	1995-08-22	Zeneca Limited	Arylindazoles and their use as herbicides
HU225869B1 (en) *	1992-04-02	2007-11-28	Smithkline Beecham Corp	Compounds with antiallergic and antiinflammatory activity and pharmaceutical compns. contg. them
US5612360A (en) *	1992-06-03	1997-03-18	Eli Lilly And Company	Angiotensin II antagonists
US5554620A (en) *	1993-09-14	1996-09-10	Sterling Winthrop Inc.	Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
JPH07215952A (ja) *	1993-12-06	1995-08-15	Otsuka Pharmaceut Factory Inc	カテコール誘導体
EP0787132A1 (en) *	1994-10-20	1997-08-06	Pfizer Inc.	Bicyclic tetrahydro pyrazolopyridines and their use as medicaments

1997
- 1997-06-02 ES ES97921992T patent/ES2201299T3/es not_active Expired - Lifetime
- 1997-06-02 SK SK1765-98A patent/SK176598A3/sk unknown
- 1997-06-02 EP EP97921992A patent/EP0912558B1/en not_active Expired - Lifetime
- 1997-06-02 IL IL12703697A patent/IL127036A/en not_active IP Right Cessation
- 1997-06-02 PL PL97330974A patent/PL330974A1/xx unknown
- 1997-06-02 TR TR1998/02685T patent/TR199802685T2/xx unknown
- 1997-06-02 PT PT97921992T patent/PT912558E/pt unknown
- 1997-06-02 DK DK97921992T patent/DK0912558T3/da active
- 1997-06-02 AU AU27857/97A patent/AU716376B2/en not_active Ceased
- 1997-06-02 CA CA002258285A patent/CA2258285C/en not_active Expired - Fee Related
- 1997-06-02 WO PCT/IB1997/000630 patent/WO1997049702A1/en not_active Ceased
- 1997-06-02 DE DE69723447T patent/DE69723447T2/de not_active Expired - Fee Related
- 1997-06-02 CZ CZ984233A patent/CZ423398A3/cs unknown
- 1997-06-02 EA EA199801047A patent/EA002274B1/ru not_active IP Right Cessation
- 1997-06-02 CN CN97195846A patent/CN1080260C/zh not_active Expired - Fee Related
- 1997-06-02 HU HU9903009A patent/HUP9903009A3/hu unknown
- 1997-06-02 JP JP50258998A patent/JP3152940B2/ja not_active Expired - Fee Related
- 1997-06-02 KR KR1019980710961A patent/KR20000022516A/ko not_active Abandoned
- 1997-06-02 AT AT97921992T patent/ATE244713T1/de not_active IP Right Cessation
- 1997-06-02 BR BR9712782-5A patent/BR9712782A/pt not_active Application Discontinuation
- 1997-06-02 SI SI9730553T patent/SI0912558T1/xx unknown
- 1997-06-05 US US08/869,358 patent/US6040329A/en not_active Expired - Fee Related
- 1997-06-05 HN HN1997000079A patent/HN1997000079A/es unknown
- 1997-06-10 PA PA19978432301A patent/PA8432301A1/es unknown
- 1997-06-12 GT GT199700075A patent/GT199700075A/es unknown
- 1997-06-19 AP APAP/P/1997/001020A patent/AP1025A/en active
- 1997-06-20 TW TW086108723A patent/TW434237B/zh not_active IP Right Cessation
- 1997-06-23 MY MYPI97002820A patent/MY116915A/en unknown
- 1997-06-23 AR ARP970102755A patent/AR007456A1/es unknown
- 1997-06-24 DZ DZ970104A patent/DZ2254A1/fr active
- 1997-06-24 ID IDP972170A patent/ID18579A/id unknown
- 1997-06-24 TN TNTNSN97108A patent/TNSN97108A1/fr unknown
- 1997-06-24 ZA ZA975581A patent/ZA975581B/xx unknown
- 1997-06-25 MA MA24679A patent/MA24225A1/fr unknown
- 1997-06-25 HR HR970350A patent/HRP970350B1/xx not_active Application Discontinuation
- 1997-06-25 CO CO97035540A patent/CO4900056A1/es unknown
1998
- 1998-11-27 IS IS4910A patent/IS4910A/is unknown
- 1998-12-11 OA OA9800235A patent/OA10934A/en unknown
- 1998-12-23 NO NO986103A patent/NO986103L/no not_active Application Discontinuation
- 1998-12-23 NZ NZ332752A patent/NZ332752A/en unknown
- 1998-12-24 YU YU60198A patent/YU60198A/sh unknown
1999
- 1999-01-07 BG BG103056A patent/BG64052B1/bg unknown

Also Published As

Publication number	Publication date
MY116915A (en)	2004-04-30
BR9712782A (pt)	1999-12-07
AU716376B2 (en)	2000-02-24
KR20000022516A (ko)	2000-04-25
GT199700075A (es)	1998-12-04
WO1997049702A1 (en)	1997-12-31
AR007456A1 (es)	1999-10-27
SI0912558T1 (en)	2003-10-31
US6040329A (en)	2000-03-21
DE69723447D1 (de)	2003-08-14
EA002274B1 (ru)	2002-02-28
OA10934A (en)	2002-02-18
JPH11514668A (ja)	1999-12-14
BG103056A (en)	1999-10-29
TR199802685T2 (xx)	1999-03-22
ZA975581B (en)	1998-12-24
SK176598A3 (en)	2000-06-12
HN1997000079A (es)	1997-12-26
DK0912558T3 (da)	2003-08-18
EP0912558B1 (en)	2003-07-09
HRP970350A2 (en)	1998-06-30
ES2201299T3 (es)	2004-03-16
CN1080260C (zh)	2002-03-06
IL127036A (en)	2001-06-14
NO986103D0 (no)	1998-12-23
AP1025A (en)	2001-11-19
TNSN97108A1 (fr)	2005-03-15
PT912558E (pt)	2003-11-28
DE69723447T2 (de)	2003-12-24
DZ2254A1 (fr)	2002-12-18
AU2785797A (en)	1998-01-14
CA2258285C (en)	2002-11-26
ATE244713T1 (de)	2003-07-15
CZ423398A3 (cs)	1999-12-15
BG64052B1 (bg)	2003-11-28
HUP9903009A2 (hu)	2000-05-28
IS4910A (is)	1998-11-27
AP9701020A0 (en)	1997-07-31
ID18579A (id)	1998-04-23
CO4900056A1 (es)	2000-03-27
YU60198A (sh)	1999-09-27
HK1018700A1 (en)	1999-12-30
IL127036A0 (en)	1999-09-22
CN1223651A (zh)	1999-07-21
EA199801047A1 (ru)	1999-06-24
JP3152940B2 (ja)	2001-04-03
HRP970350B1 (en)	2003-04-30
MA24225A1 (fr)	1997-12-31
CA2258285A1 (en)	1997-12-31
NZ332752A (en)	2001-04-27
EP0912558A1 (en)	1999-05-06
HUP9903009A3 (en)	2002-01-28
TW434237B (en)	2001-05-16
PA8432301A1 (es)	1999-12-27
PL330974A1 (en)	1999-06-21

Publication	Publication Date	Title
NO986103L (no)	1998-12-23	Substituerte indazol-derivater og deres anvendelse som fosfodiesterase (PDE)type IV - og tumornekrose-faktor (TNF)inhibitorer
NO991048D0 (no)	1999-03-03	Indazolderivater og deres anvendelse som inhibitorer av fosfodiesterase (PDE) type IV og fremstillingen av tumornekrosefaktor (TNF)
NO985095D0 (no)	1998-11-02	Substituerte indazolderivater og deres anvendelse som inhibitorer fosfodiesterase (PDE) type IV og produksjon av tumornekrosefaktor (TNF)
DK1475377T3 (da)	2006-10-23	Indol-derivater og deres anvendelse som inhibitorer for phosphodiesterase 4
DK1000039T3 (da)	2004-08-16	Substituerede quinazolinderivater og anvendelse deraf som tyrosinkinaseinhibitorer
NO20015797D0 (no)	2001-11-28	Indazolforbindelser og farmasöytiske forbindelser for inhibering av proteinkinaser, og fremgangsmåter til anvendelsederav
FI981437A7 (fi)	1998-08-25	PDE III, PDE IV ja TNF inhibiittoreina käyttökelpoisia imidejä
FI950859A7 (fi)	1995-02-24	Arylideeni- ja heteroarylideeni-oksindolijohdannaiset tyrosiinikinaasi-inhibiittoreina
NO20001102D0 (no)	2000-03-03	2,3-diaryl-pyrazolo[1,5-B]pyridazinderivater, deres fremstilling og anvendelse som syklo-oksygenase 2 (COX-2) inhibitorer
NO20030958D0 (no)	2003-02-28	Pyrazolderivater og deres anvendelse som proteinkinase inhibitorer
NO20026010L (no)	2002-12-13	Substituerte quinazolinderivater og deres anvendelse som inhibitorer
NO985577D0 (no)	1998-11-27	Alkyloksyaminosubstituerte fluorenoner og deres anvendelse som proteinkinase C-inhibitorer
DK0983249T3 (da)	2002-07-08	Fremgangsmåder og mellemprodukter til fremstilling af substituerede indazolderivater
NO934227D0 (no)	1993-11-23	Pyrrolderivater, fremgangsm}te for deres fremstilling og terapeutiske anvendelse
NO20003199D0 (no)	2000-06-20	Benzo(C)kinolizinderivater og deres anvendelse som 5- <alfa>reduktaseinhibitorer

Legal Events

Date	Code	Title	Description
2006-04-10	FC2A	Withdrawal, rejection or dismissal of laid open patent application